The “Schweizerischen Ärztezeitung” (the Swiss Medical Journal) recently reported on ELZA’s consultant glaucoma surgeon, Prof. Dr. med. Kaweh Mansouri’s appointment as the Executive Vice President of the World Glaucoma Association (WGA) in an article titled “He fights against glaucoma”. This appointment marks the first time a Swiss and European specialist has been elected to this position within the WGA.
The article reviews Prof. Mansouri’s career and describes how he completed his medical studies in Vienna, Austria, followed by specialty training in ophthalmology. His career progression over the years included a senior role at the University of Geneva’s glaucoma department and further research work at the Hamilton Glaucoma Center at the University of California, USA, with Prof. Robert Weinreb, where he deepened his focus on the neurodegenerative nature of the disease and its surgical treatments. Earlier in his career, Prof. Mansouri was recognized in 2015 by The Ophthalmologist as one of the “Top 40 under 40” personalities in the field of ophthalmology, and again in 2024 as a member of the main Power List.
Prof. Mansouri has also been recognized for his contributions to ophthalmology through research and innovation. He holds patents for new diagnostic devices and has authored over 100 peer-reviewed articles and book chapters. His role in founding the Swiss Glaucoma Research Foundation with Prof. Dr. med. André Mermoud has been pivotal in advancing the field.
As reported by the “Schweizerischen Ärztezeitung,” in his role at the WGA, Prof. Mansouri aims to expand the organization’s membership and support the development of future researchers in the field. He is optimistic about the future of glaucoma treatment, particularly the potential for gene therapies and neuroprotective treatments to significantly improve patient outcomes.
Prof. Mansouri’s appointment reflects his ongoing commitment to research and his active role in promoting improved treatment strategies and patient care on a global scale. His leadership in the WGA is expected to further international efforts to understand and treat glaucoma more effectively.
A PDF of the article is available to read aqui.
